Welcome to our dedicated page for Nasdaq news (Ticker: NDAQ), a resource for investors and traders seeking the latest updates and insights on Nasdaq stock.
Nasdaq, Inc. (symbol: NDAQ) is a global technology company and a leading provider of capital market services, established in 1971. Initially known for its equity exchange, Nasdaq has evolved into a diversified technology provider that delivers solutions across multiple segments, including market services, information services, and corporate services.
Market Services: This segment represents approximately 35% of Nasdaq's revenue and includes trading, clearing, and market technology services. Nasdaq operates one of the world's largest electronic stock exchanges, facilitating efficient and reliable trading.
Information Services: Contributing about 30% of the company's sales, this segment offers market data, analytics, and Nasdaq-branded indexes to asset managers and investors, providing essential tools for informed decision-making.
Corporate Services: Accounting for 20% of revenue, Nasdaq's corporate services include listing services and investor relations products that support publicly traded companies in meeting their regulatory requirements and enhancing investor engagement.
Market Technology: Representing 15% of the firm's revenue, this segment delivers technology solutions that enable the operation of other exchanges around the world, as well as financial compliance services.
Recent Achievements: Nasdaq continues to be at the forefront of technological advancements, incorporating AI capabilities to support capital markets, thereby enhancing liquidity, transparency, and integrity in the financial ecosystem. The company is also involved in strategic partnerships, such as its recent collaboration with FIA Tech to improve data sharing and reduce systemic inefficiency in the global post-trade network.
With a strong commitment to innovation, Nasdaq has successfully transitioned from a U.S.-based equities exchange to a global leader in technology and information services. The company's diverse product offerings and client-centric approach enable businesses to optimize their operations and achieve their business goals with confidence.
Financial Overview: Nasdaq's financial performance has been robust, with consistent revenue growth driven by its diversified business model. The company's strategic investments and focus on scalability and efficiency have positioned it well for sustained growth and profitability.
For the latest updates, financial results, and developments, visit the Nasdaq Investor Relations website at http://ir.nasdaq.com.
Nasdaq (NDAQ) has announced a minority investment in UK-based financial crime investigation automation company Caspian. This partnership aims to enhance Caspian's automated anti-money laundering solutions and accelerate its product expansion. Nasdaq Ventures seeks to invest in technology disruptors that improve market transparency. Caspian's machine learning technologies promise increased productivity and cost savings for compliance teams in banks. The terms of the investment remain undisclosed, but the collaboration is expected to bolster both companies' capabilities in combating financial crime.
The Nasdaq Stock Market announced the delisting of Akazoo S.A.'s ordinary shares and warrant, effective ten days after filing a Form 25 with the SEC. The shares were suspended from trading on May 27, 2020, and have not traded since. Investors should refer to public filings for more information regarding the basis for the delisting and the status of the company's securities on other venues.
Nasdaq (NDAQ) announced its monthly trading volumes for May 2020, providing details on trading activity during the month. This information can be accessed through their investor relations website. The report highlights Nasdaq's ongoing efforts to keep stakeholders informed about trading metrics and market activities.
The Nasdaq Stock Market (NDAQ) has announced that trading in CNS Pharmaceuticals Inc. (CNSP) will resume on May 28, 2020, at 7:00 a.m. Eastern Time. This follows a trading halt initiated on May 4, 2020, at 9:25:06 Eastern Time. The resumption of trading is significant for investors and reflects the ongoing activities of CNS Pharmaceuticals. For more details, stakeholders can look under the company's symbol on the Nasdaq website.
The Nasdaq Stock Market (Nasdaq: NDAQ) has announced that trading of Moleculin Biotech, Inc. (Nasdaq: MBRX) will resume on May 28, 2020, at 7:00 a.m. Eastern Time. The trading was halted on May 4, 2020, at 9:25:06 a.m. Eastern Time. This resumption signifies the end of the trading disruption for MBRX stocks, allowing investors to re-engage with the market.
On May 26, 2020, Nasdaq CEO Adena Friedman announced her participation in two upcoming events. The first, Bernstein’s 36th Annual Strategic Decisions Conference, will take place on May 28, 2020, at 10:00 AM ET. The second event is the Piper Sandler Global Exchange & FinTech Conference, scheduled for June 4, 2020, also at 10:00 AM ET. Both presentations will be available via webcast on Nasdaq's Investor Relations website.
Nasdaq announced that trading in Luckin Coffee Inc. (NDAQ: LK) will resume on May 20, 2020, at 7:00 a.m. Eastern Time. The stock was halted on April 7, 2020, at 9:15:25 Eastern Time due to regulatory issues. This resumption follows the company's efforts to address compliance matters. For further details, investors can access information under the company’s symbol using InfoQuotes on the Nasdaq website.
The Nasdaq Stock Market (NDAQ) announced that the trading halt on CNS Pharmaceuticals Inc. (CNSP) has been switched to an "additional information requested" status. This trading halt began on May 4, 2020, at 9:25:06 Eastern Time, with a last sale price of $2.76. Trading will remain suspended until CNS Pharmaceuticals Inc. provides the required information to Nasdaq.
For further updates, stakeholders are advised to check the Nasdaq website or directly contact the company.
The Nasdaq Stock Market (NDAQ) announced on May 18, 2020, that trading in Moleculin Biotech Inc. (MBRX) has been halted since May 4, due to a request for additional information from the company. The last sale price before the halt was $1.07. Trading will remain suspended until Moleculin Biotech provides the required information to Nasdaq.
The Nasdaq Stock Market (NDAQ) has revised the trading halt status for SCWorx Corp. (WORX) to "additional information requested" as of May 6, 2020. The company's stock was initially halted on April 22, 2020, at a price of $5.755. Trading will remain suspended until SCWorx Corp. provides the necessary information to Nasdaq.
FAQ
What is the current stock price of Nasdaq (NDAQ)?
What is the market cap of Nasdaq (NDAQ)?
What services does Nasdaq, Inc. provide?
When was Nasdaq founded?
What is Nasdaq's market services segment?
How does Nasdaq support capital markets with technology?
What are Nasdaq's recent strategic initiatives?
What percentage of Nasdaq's revenue comes from information services?
What are Nasdaq's corporate services?
What is the role of Nasdaq's market technology segment?
Where can I find Nasdaq's latest financial results?
How has Nasdaq evolved over the years?
